Mary Chappell, Deborah Watkins, Alice Sanderson, Lavinia Ferrante di Ruffano, Paul Miller, Hariet Fewster, Anita Fitzgerald, Mary Edwards, Rachael McCool
{"title":"Single-arm interventional versus observational studies for assessing efficacy: A meta-epidemiological study","authors":"Mary Chappell,&nbsp;Deborah Watkins,&nbsp;Alice Sanderson,&nbsp;Lavinia Ferrante di Ruffano,&nbsp;Paul Miller,&nbsp;Hariet Fewster,&nbsp;Anita Fitzgerald,&nbsp;Mary Edwards,&nbsp;Rachael McCool","doi":"10.1002/cesm.70016","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Interventional single-arm trials (SATs) are increasingly being used as evidence, despite a lack of agreement on their validity and where they should sit in the hierarchy of evidence. We conducted a meta-epidemiological study to investigate whether there are systematic differences in outcomes and levels of between-study heterogeneity for SATs compared with their observational counterpart, single-arm cohort studies.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We identified systematic reviews (SRs) of pharmacological interventions, published in 2023, that included both interventional and observational single-arm studies. For each SR, subgroup meta-analysis of dichotomous outcomes was conducted for included SATs and single-arm cohort studies to assess effect sizes, levels of heterogeneity and between group differences. In a sensitivity analysis, clinically heterogeneous primary studies were removed and analyses re-run.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>66 SRs contained single-arm studies, of which 13 reported meta-analyses of dichotomous efficacy outcomes. There was no overall risk difference for SATs compared with single-arm cohort studies (risk difference: −0.020, 95% CI: −0.092 to 0.052, <i>p</i> = 0.59). In the sensitivity analysis, there was a tendency to higher effect for single-arm cohort studies, but no significant difference (risk difference: −0.071, 95% CI: −0.161, 0.019, <i>p</i> = 0.12). There were high levels of between-study heterogeneity within both SATs (median; range <i>I</i><sup>2</sup>: 54.8; 11.3–91.0) and single-arm cohorts (median; range <i>I</i><sup>2</sup>: 77.2; 0–94.7) and heterogeneity remained high in the sensitivity analysis.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>There do not appear to be systematic differences in outcome between SATs and single-arm cohort studies, but further research is recommended to confirm this finding. Levels of heterogeneity are high within both designs, even after attempts to reduce clinical heterogeneity. Because clinical heterogeneity had potentially been removed, remaining statistical heterogeneity may have been due to bias related to study conduct. Future work should utilize larger samples and additional methods to further clarify the relative validity of single-arm designs.</p>\n </section>\n </div>","PeriodicalId":100286,"journal":{"name":"Cochrane Evidence Synthesis and Methods","volume":"3 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cesm.70016","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cochrane Evidence Synthesis and Methods","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cesm.70016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

导语干入性单臂试验(SATs)越来越多地被用作证据,尽管对其有效性和它们在证据层次中的位置缺乏一致意见。我们进行了一项荟萃流行病学研究,以调查与观察性单臂队列研究相比,SATs的结果和研究间异质性水平是否存在系统性差异。方法:我们检索了发表于2023年的药物干预的系统综述(SRs),其中包括干预性和观察性单臂研究。对于每个SR,对纳入的sat和单臂队列研究进行二分类结果的亚组荟萃分析,以评估效应大小、异质性水平和组间差异。在敏感性分析中,临床异质性的原始研究被删除并重新进行分析。结果66项SRs包含单组研究,其中13项报告了二元疗效结果的荟萃分析。与单臂队列研究相比,SATs没有总体风险差异(风险差异:- 0.020,95% CI: - 0.092至0.052,p = 0.59)。在敏感性分析中,单臂队列研究有较高效果的趋势,但无显著差异(风险差异:- 0.071,95% CI: - 0.161, 0.019, p = 0.12)。两种sat的研究间异质性都很高(中位数;范围I2: 54.8;11.3-91.0)和单臂队列(中位数;范围I2: 77.2;0-94.7),在敏感性分析中异质性仍然很高。SATs和单臂队列研究的结果似乎没有系统性差异,但建议进一步研究来证实这一发现。即使在试图减少临床异质性之后,两种设计的异质性水平仍然很高。由于临床异质性可能已被消除,剩余的统计异质性可能是由于与研究行为相关的偏倚。未来的工作应该利用更大的样本和更多的方法来进一步阐明单臂设计的相对有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Single-arm interventional versus observational studies for assessing efficacy: A meta-epidemiological study

Single-arm interventional versus observational studies for assessing efficacy: A meta-epidemiological study

Introduction

Interventional single-arm trials (SATs) are increasingly being used as evidence, despite a lack of agreement on their validity and where they should sit in the hierarchy of evidence. We conducted a meta-epidemiological study to investigate whether there are systematic differences in outcomes and levels of between-study heterogeneity for SATs compared with their observational counterpart, single-arm cohort studies.

Methods

We identified systematic reviews (SRs) of pharmacological interventions, published in 2023, that included both interventional and observational single-arm studies. For each SR, subgroup meta-analysis of dichotomous outcomes was conducted for included SATs and single-arm cohort studies to assess effect sizes, levels of heterogeneity and between group differences. In a sensitivity analysis, clinically heterogeneous primary studies were removed and analyses re-run.

Results

66 SRs contained single-arm studies, of which 13 reported meta-analyses of dichotomous efficacy outcomes. There was no overall risk difference for SATs compared with single-arm cohort studies (risk difference: −0.020, 95% CI: −0.092 to 0.052, p = 0.59). In the sensitivity analysis, there was a tendency to higher effect for single-arm cohort studies, but no significant difference (risk difference: −0.071, 95% CI: −0.161, 0.019, p = 0.12). There were high levels of between-study heterogeneity within both SATs (median; range I2: 54.8; 11.3–91.0) and single-arm cohorts (median; range I2: 77.2; 0–94.7) and heterogeneity remained high in the sensitivity analysis.

Conclusion

There do not appear to be systematic differences in outcome between SATs and single-arm cohort studies, but further research is recommended to confirm this finding. Levels of heterogeneity are high within both designs, even after attempts to reduce clinical heterogeneity. Because clinical heterogeneity had potentially been removed, remaining statistical heterogeneity may have been due to bias related to study conduct. Future work should utilize larger samples and additional methods to further clarify the relative validity of single-arm designs.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信